1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Polshakov, V.I.
Smirnov, E.G.
Birdsall, B.
Kelly, G.
Feeney, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C21 H30 N7 O17 P3
745.421
NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C14 H19 N4 O3 1
291.326
2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM
non-polymer
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
J.Biomol.Nmr
JBNME9
0800
0925-2738
24
67
70
10.1023/A:1020659713373
12449420
NMR-based solution structure of the complex of Lactobacillus casei dihydrofolate reductase with trimethoprim and NADPH
2002
NE
J.Mol.Struct.
JMOSB4
0119
0022-2860
602
257
267
10.1016/S0022-2860(01)00687-1
Towards understanding the origins of the different specificities of binding the reduced (NADPH) and oxydised (NADP+) forms of nicotinamide adenine dinucleotide phosphate coenzyme to dihydrofolate reductase
2002
US
Biochemistry
BICHAW
0033
0006-2960
38
15962
15969
10.1021/bi9915263
10625463
Characterization of rates of ring-flipping in trimethoprim in its ternary complexes with Lactobacillus casei dihydrofolate reductase and coenzyme analogues
1999
US
Protein Sci.
PRCIEI
0795
0961-8368
8
467
481
10.1110/ps.8.3.467
10091649
Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate
1999
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
277
119
134
10.1006/jmbi.1997.1560
The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate
1998
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
18331.594
DIHYDROFOLATE REDUCTASE
1.5.1.3
1
man
polymer
745.421
NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
1
syn
non-polymer
291.326
2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM
1
syn
non-polymer
no
no
TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA
AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK
KA
TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA
AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK
KA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lactobacillus
Escherichia
sample
1582
Lactobacillus casei
562
Escherichia coli
NF1
PLASMID
PMT702
repository
Initial release
Version format compliance
Version format compliance
Database references
1
0
2002-12-18
1
1
2008-04-28
1
2
2011-07-13
1
3
2016-12-28
1BZF contains THE SAME PROTEIN COMPLEXED WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE
1AO8 contains THE SAME PROTEIN COMPLEXED WITH METHOTREXATE
3DFR contains crystal structure of THE SAME PROTEIN COMPLEXED WITH NADPH AND METHOTREXATE
RCSB
Y
PDBJ
2002-05-22
REL
REL
NDP
NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
TRR
2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM
structures with the least restraint violations
32
24
3D_15N-separated_NOESY
HNHA
3D_15N-separated_ROESY
2D_N15-rejected_NOESY
2D NOESY
DQF-COSY
J-modulated N15, H1-HSQC
J-modulated N15, H1-HSQC
100 mM KCl
6.5
ambient
308
K
10 ps at 1000K, 40 ps cooling from 1000 to 0K, 1000 steps of EM
simulated annealing
1
closest to the average
3mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer
90% H2O/10% D2O
3 mM DHFR/TMP/NADPH, 50 mM phosphate buffer
100% D2O
0.5mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer, 5% DMPC/DHPC (3:1)
90% H2O/10% D2O
0.25mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer, 5% C12E5/hexanol
90% H2O/10% D2O
Varian
collection
VNMR
6.1
Delaglio
processing
NMRPipe
1998-2001
Brunger
structure solution
CNS
0.9
Brunger
refinement
CNS
1.0
500
Varian
UNITYPLUS
600
Varian
UNITY
600
Varian
INOVA
NDP
168
2
NDP
NDP
168
A
TRR
170
3
TRR
TRR
170
A
THR
1
n
1
THR
1
A
ALA
2
n
2
ALA
2
A
PHE
3
n
3
PHE
3
A
LEU
4
n
4
LEU
4
A
TRP
5
n
5
TRP
5
A
ALA
6
n
6
ALA
6
A
GLN
7
n
7
GLN
7
A
ASP
8
n
8
ASP
8
A
ARG
9
n
9
ARG
9
A
ASP
10
n
10
ASP
10
A
GLY
11
n
11
GLY
11
A
LEU
12
n
12
LEU
12
A
ILE
13
n
13
ILE
13
A
GLY
14
n
14
GLY
14
A
LYS
15
n
15
LYS
15
A
ASP
16
n
16
ASP
16
A
GLY
17
n
17
GLY
17
A
HIS
18
n
18
HIS
18
A
LEU
19
n
19
LEU
19
A
PRO
20
n
20
PRO
20
A
TRP
21
n
21
TRP
21
A
HIS
22
n
22
HIS
22
A
LEU
23
n
23
LEU
23
A
PRO
24
n
24
PRO
24
A
ASP
25
n
25
ASP
25
A
ASP
26
n
26
ASP
26
A
LEU
27
n
27
LEU
27
A
HIS
28
n
28
HIS
28
A
TYR
29
n
29
TYR
29
A
PHE
30
n
30
PHE
30
A
ARG
31
n
31
ARG
31
A
ALA
32
n
32
ALA
32
A
GLN
33
n
33
GLN
33
A
THR
34
n
34
THR
34
A
VAL
35
n
35
VAL
35
A
GLY
36
n
36
GLY
36
A
LYS
37
n
37
LYS
37
A
ILE
38
n
38
ILE
38
A
MET
39
n
39
MET
39
A
VAL
40
n
40
VAL
40
A
VAL
41
n
41
VAL
41
A
GLY
42
n
42
GLY
42
A
ARG
43
n
43
ARG
43
A
ARG
44
n
44
ARG
44
A
THR
45
n
45
THR
45
A
TYR
46
n
46
TYR
46
A
GLU
47
n
47
GLU
47
A
SER
48
n
48
SER
48
A
PHE
49
n
49
PHE
49
A
PRO
50
n
50
PRO
50
A
LYS
51
n
51
LYS
51
A
ARG
52
n
52
ARG
52
A
PRO
53
n
53
PRO
53
A
LEU
54
n
54
LEU
54
A
PRO
55
n
55
PRO
55
A
GLU
56
n
56
GLU
56
A
ARG
57
n
57
ARG
57
A
THR
58
n
58
THR
58
A
ASN
59
n
59
ASN
59
A
VAL
60
n
60
VAL
60
A
VAL
61
n
61
VAL
61
A
LEU
62
n
62
LEU
62
A
THR
63
n
63
THR
63
A
HIS
64
n
64
HIS
64
A
GLN
65
n
65
GLN
65
A
GLU
66
n
66
GLU
66
A
ASP
67
n
67
ASP
67
A
TYR
68
n
68
TYR
68
A
GLN
69
n
69
GLN
69
A
ALA
70
n
70
ALA
70
A
GLN
71
n
71
GLN
71
A
GLY
72
n
72
GLY
72
A
ALA
73
n
73
ALA
73
A
VAL
74
n
74
VAL
74
A
VAL
75
n
75
VAL
75
A
VAL
76
n
76
VAL
76
A
HIS
77
n
77
HIS
77
A
ASP
78
n
78
ASP
78
A
VAL
79
n
79
VAL
79
A
ALA
80
n
80
ALA
80
A
ALA
81
n
81
ALA
81
A
VAL
82
n
82
VAL
82
A
PHE
83
n
83
PHE
83
A
ALA
84
n
84
ALA
84
A
TYR
85
n
85
TYR
85
A
ALA
86
n
86
ALA
86
A
LYS
87
n
87
LYS
87
A
GLN
88
n
88
GLN
88
A
HIS
89
n
89
HIS
89
A
PRO
90
n
90
PRO
90
A
ASP
91
n
91
ASP
91
A
GLN
92
n
92
GLN
92
A
GLU
93
n
93
GLU
93
A
LEU
94
n
94
LEU
94
A
VAL
95
n
95
VAL
95
A
ILE
96
n
96
ILE
96
A
ALA
97
n
97
ALA
97
A
GLY
98
n
98
GLY
98
A
GLY
99
n
99
GLY
99
A
ALA
100
n
100
ALA
100
A
GLN
101
n
101
GLN
101
A
ILE
102
n
102
ILE
102
A
PHE
103
n
103
PHE
103
A
THR
104
n
104
THR
104
A
ALA
105
n
105
ALA
105
A
PHE
106
n
106
PHE
106
A
LYS
107
n
107
LYS
107
A
ASP
108
n
108
ASP
108
A
ASP
109
n
109
ASP
109
A
VAL
110
n
110
VAL
110
A
ASP
111
n
111
ASP
111
A
THR
112
n
112
THR
112
A
LEU
113
n
113
LEU
113
A
LEU
114
n
114
LEU
114
A
VAL
115
n
115
VAL
115
A
THR
116
n
116
THR
116
A
ARG
117
n
117
ARG
117
A
LEU
118
n
118
LEU
118
A
ALA
119
n
119
ALA
119
A
GLY
120
n
120
GLY
120
A
SER
121
n
121
SER
121
A
PHE
122
n
122
PHE
122
A
GLU
123
n
123
GLU
123
A
GLY
124
n
124
GLY
124
A
ASP
125
n
125
ASP
125
A
THR
126
n
126
THR
126
A
LYS
127
n
127
LYS
127
A
MET
128
n
128
MET
128
A
ILE
129
n
129
ILE
129
A
PRO
130
n
130
PRO
130
A
LEU
131
n
131
LEU
131
A
ASN
132
n
132
ASN
132
A
TRP
133
n
133
TRP
133
A
ASP
134
n
134
ASP
134
A
ASP
135
n
135
ASP
135
A
PHE
136
n
136
PHE
136
A
THR
137
n
137
THR
137
A
LYS
138
n
138
LYS
138
A
VAL
139
n
139
VAL
139
A
SER
140
n
140
SER
140
A
SER
141
n
141
SER
141
A
ARG
142
n
142
ARG
142
A
THR
143
n
143
THR
143
A
VAL
144
n
144
VAL
144
A
GLU
145
n
145
GLU
145
A
ASP
146
n
146
ASP
146
A
THR
147
n
147
THR
147
A
ASN
148
n
148
ASN
148
A
PRO
149
n
149
PRO
149
A
ALA
150
n
150
ALA
150
A
LEU
151
n
151
LEU
151
A
THR
152
n
152
THR
152
A
HIS
153
n
153
HIS
153
A
THR
154
n
154
THR
154
A
TYR
155
n
155
TYR
155
A
GLU
156
n
156
GLU
156
A
VAL
157
n
157
VAL
157
A
TRP
158
n
158
TRP
158
A
GLN
159
n
159
GLN
159
A
LYS
160
n
160
LYS
160
A
LYS
161
n
161
LYS
161
A
ALA
162
n
162
ALA
162
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
76
A
O
VAL
76
A
N
VAL
61
A
N
VAL
61
A
O
VAL
60
A
O
VAL
60
A
N
MET
39
A
N
MET
39
A
N
VAL
40
A
N
VAL
40
A
O
VAL
95
A
O
VAL
95
A
O
ILE
96
A
O
ILE
96
A
N
ALA
2
A
N
ALA
2
A
N
PHE
3
A
N
PHE
3
A
O
THR
112
A
O
THR
112
A
N
LEU
113
A
N
LEU
113
A
O
TRP
158
A
O
TRP
158
A
O
TYR
155
A
O
TYR
155
A
N
ARG
142
A
N
ARG
142
1
A
A
O
H
ALA
ILE
2
96
1.56
2
A
A
O
H
ALA
ILE
2
96
1.57
3
A
A
O
H
ALA
ILE
2
96
1.56
5
A
A
O
H
ALA
ILE
2
96
1.59
6
A
A
O
H
ALA
ILE
2
96
1.56
8
A
A
O
H
ALA
ILE
2
96
1.59
10
A
A
O
H
ALA
ILE
2
96
1.58
12
A
A
O
H
ALA
ILE
2
96
1.57
13
A
A
O
H
ALA
ILE
2
96
1.59
15
A
A
O
H
ALA
ILE
2
96
1.57
16
A
A
O
H
ALA
ILE
2
96
1.59
17
A
A
O
H
ALA
ILE
2
96
1.56
17
A
A
H
O
VAL
VAL
61
74
1.60
18
A
A
O
H
ALA
ILE
2
96
1.59
20
A
A
O
H
ALA
ILE
2
96
1.56
1
A
ILE
13
-130.91
-67.44
1
A
PHE
49
-48.56
154.91
1
A
ASP
78
-167.99
108.70
1
A
ASP
91
-141.31
11.51
1
A
ASP
111
-131.36
-35.60
2
A
TRP
21
-113.84
-159.38
2
A
ASP
78
-166.86
106.80
2
A
GLU
93
-87.28
-159.84
3
A
ILE
13
-133.43
-63.32
3
A
TRP
21
-114.45
-157.51
3
A
PRO
55
-48.69
156.12
3
A
GLU
56
49.64
23.10
3
A
ASP
78
-167.86
109.86
3
A
ASP
91
-143.10
10.45
4
A
LEU
19
-49.91
154.36
4
A
PHE
49
-44.64
159.83
4
A
ASP
78
-167.56
113.33
4
A
ASP
91
-141.17
10.93
5
A
ILE
13
-122.33
-65.77
5
A
HIS
18
-56.67
-167.93
5
A
PHE
49
-43.22
159.90
5
A
ASP
78
-166.08
111.05
6
A
ILE
13
-131.29
-66.88
6
A
HIS
18
-56.28
-165.93
6
A
ASP
78
-166.74
114.19
6
A
PRO
130
-54.03
99.20
7
A
ILE
13
-135.70
-62.58
7
A
HIS
18
-58.18
-165.81
7
A
PHE
49
-45.10
150.59
7
A
ASP
78
-167.19
111.54
7
A
PRO
130
-66.59
96.58
8
A
ILE
13
-121.31
-66.74
8
A
ASP
78
-168.75
111.39
8
A
GLU
93
-90.67
-158.25
9
A
HIS
18
-56.66
-165.58
9
A
PHE
49
-46.12
161.88
9
A
ASP
78
-166.04
109.23
10
A
ILE
13
-129.71
-63.14
10
A
ASP
78
-167.53
114.18
10
A
PRO
130
-58.79
99.27
11
A
HIS
18
-57.68
-166.57
11
A
TRP
21
-113.23
-158.77
11
A
PHE
49
-47.06
154.77
11
A
ASP
78
-168.78
107.18
11
A
ASP
91
-140.33
10.82
12
A
ILE
13
-130.95
-67.30
12
A
LEU
19
-48.93
164.32
12
A
TRP
21
-112.98
-158.57
12
A
ASP
78
-166.43
108.13
13
A
HIS
18
-55.25
-171.62
13
A
GLU
56
49.95
22.96
13
A
HIS
77
-141.45
33.73
13
A
ASP
78
-167.88
108.94
13
A
ASP
91
-140.59
13.00
13
A
ASP
111
-134.41
-31.01
14
A
ILE
13
-127.70
-67.41
14
A
HIS
18
-54.78
-175.09
14
A
PHE
49
-49.11
155.75
14
A
PRO
55
-68.82
93.44
14
A
ASP
78
-165.78
105.35
15
A
HIS
18
-56.81
-166.13
15
A
TRP
21
-112.01
-157.87
15
A
PHE
49
-48.36
156.98
15
A
ASP
78
-167.31
108.66
15
A
ASP
91
-140.11
10.50
16
A
HIS
18
-54.29
-174.72
16
A
PHE
49
-48.07
164.32
16
A
ASP
78
-168.11
108.75
17
A
ILE
13
-127.47
-68.04
17
A
ASP
78
-170.14
112.95
17
A
ASP
91
-140.76
11.22
18
A
ILE
13
-129.31
-66.89
18
A
HIS
18
-54.31
-173.42
18
A
ASP
78
-167.32
109.65
18
A
ASP
91
-140.74
13.13
18
A
ASP
111
-132.09
-35.26
19
A
ILE
13
-133.23
-56.91
19
A
HIS
18
-58.26
-163.55
19
A
PHE
49
-49.22
152.70
19
A
ASP
78
-165.10
106.63
19
A
PRO
130
-66.89
99.88
20
A
ILE
13
-121.87
-68.38
20
A
PHE
49
-47.93
153.80
20
A
ASP
78
-168.13
107.79
21
A
TRP
21
-111.93
-157.43
21
A
ASP
78
-166.70
107.91
21
A
GLU
93
-87.58
-157.70
22
A
ILE
13
-134.57
-61.61
22
A
PHE
49
-44.88
155.56
22
A
ASP
78
-163.53
107.98
22
A
ASP
111
-131.41
-33.03
23
A
PHE
49
-41.13
159.27
23
A
ASP
78
-169.33
113.18
24
A
PHE
49
-43.64
154.22
24
A
ASP
78
-167.83
110.19
DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3)
SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH, 24 STRUCTURES
1
N
N
2
N
N
3
N
N
A
LEU
23
A
LEU
23
HELX_P
A
THR
34
A
THR
34
1
1
12
A
ARG
43
A
ARG
43
HELX_P
A
PHE
49
A
PHE
49
1
2
7
A
ASP
78
A
ASP
78
HELX_P
A
HIS
89
A
HIS
89
1
3
12
A
GLY
99
A
GLY
99
HELX_P
A
PHE
106
A
PHE
106
1
4
8
A
ASN
132
A
ASN
132
HELX_P
A
ASP
134
A
ASP
134
5
5
3
OXIDOREDUCTASE
DHFR, INHIBITOR-ENZYME COMPLEX, OXIDOREDUCTASE
A
ARG
52
A
ARG
52
1
A
PRO
53
A
PRO
53
-0.88
A
GLY
98
A
GLY
98
1
A
GLY
99
A
GLY
99
0.96
A
ARG
52
A
ARG
52
2
A
PRO
53
A
PRO
53
-0.97
A
GLY
98
A
GLY
98
2
A
GLY
99
A
GLY
99
0.89
A
ARG
52
A
ARG
52
3
A
PRO
53
A
PRO
53
-0.44
A
GLY
98
A
GLY
98
3
A
GLY
99
A
GLY
99
1.04
A
ARG
52
A
ARG
52
4
A
PRO
53
A
PRO
53
-0.12
A
GLY
98
A
GLY
98
4
A
GLY
99
A
GLY
99
1.00
A
ARG
52
A
ARG
52
5
A
PRO
53
A
PRO
53
-0.88
A
GLY
98
A
GLY
98
5
A
GLY
99
A
GLY
99
1.00
A
ARG
52
A
ARG
52
6
A
PRO
53
A
PRO
53
0.01
A
GLY
98
A
GLY
98
6
A
GLY
99
A
GLY
99
1.00
A
ARG
52
A
ARG
52
7
A
PRO
53
A
PRO
53
0.50
A
GLY
98
A
GLY
98
7
A
GLY
99
A
GLY
99
1.38
A
ARG
52
A
ARG
52
8
A
PRO
53
A
PRO
53
-0.22
A
GLY
98
A
GLY
98
8
A
GLY
99
A
GLY
99
0.91
A
ARG
52
A
ARG
52
9
A
PRO
53
A
PRO
53
-0.28
A
GLY
98
A
GLY
98
9
A
GLY
99
A
GLY
99
0.91
A
ARG
52
A
ARG
52
10
A
PRO
53
A
PRO
53
-0.67
A
GLY
98
A
GLY
98
10
A
GLY
99
A
GLY
99
1.34
A
ARG
52
A
ARG
52
11
A
PRO
53
A
PRO
53
-1.04
A
GLY
98
A
GLY
98
11
A
GLY
99
A
GLY
99
0.81
A
ARG
52
A
ARG
52
12
A
PRO
53
A
PRO
53
-0.32
A
GLY
98
A
GLY
98
12
A
GLY
99
A
GLY
99
0.92
A
ARG
52
A
ARG
52
13
A
PRO
53
A
PRO
53
-0.22
A
GLY
98
A
GLY
98
13
A
GLY
99
A
GLY
99
1.06
A
ARG
52
A
ARG
52
14
A
PRO
53
A
PRO
53
-0.71
A
GLY
98
A
GLY
98
14
A
GLY
99
A
GLY
99
1.10
A
ARG
52
A
ARG
52
15
A
PRO
53
A
PRO
53
-0.67
A
GLY
98
A
GLY
98
15
A
GLY
99
A
GLY
99
1.03
A
ARG
52
A
ARG
52
16
A
PRO
53
A
PRO
53
-0.84
A
GLY
98
A
GLY
98
16
A
GLY
99
A
GLY
99
0.90
A
ARG
52
A
ARG
52
17
A
PRO
53
A
PRO
53
-0.94
A
GLY
98
A
GLY
98
17
A
GLY
99
A
GLY
99
1.23
A
ARG
52
A
ARG
52
18
A
PRO
53
A
PRO
53
-0.48
A
GLY
98
A
GLY
98
18
A
GLY
99
A
GLY
99
1.09
A
ARG
52
A
ARG
52
19
A
PRO
53
A
PRO
53
-0.98
A
GLY
98
A
GLY
98
19
A
GLY
99
A
GLY
99
1.23
A
ARG
52
A
ARG
52
20
A
PRO
53
A
PRO
53
0.07
A
GLY
98
A
GLY
98
20
A
GLY
99
A
GLY
99
1.13
A
ARG
52
A
ARG
52
21
A
PRO
53
A
PRO
53
-0.57
A
GLY
98
A
GLY
98
21
A
GLY
99
A
GLY
99
1.16
A
ARG
52
A
ARG
52
22
A
PRO
53
A
PRO
53
-0.02
A
GLY
98
A
GLY
98
22
A
GLY
99
A
GLY
99
1.29
A
ARG
52
A
ARG
52
23
A
PRO
53
A
PRO
53
0.06
A
GLY
98
A
GLY
98
23
A
GLY
99
A
GLY
99
1.03
A
ARG
52
A
ARG
52
24
A
PRO
53
A
PRO
53
0.15
A
GLY
98
A
GLY
98
24
A
GLY
99
A
GLY
99
1.05
DYR_LACCA
UNP
1
1
P00381
TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA
AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK
KA
1
162
1LUD
1
162
P00381
A
1
1
162
8
parallel
parallel
parallel
parallel
parallel
anti-parallel
anti-parallel
A
VAL
74
A
VAL
74
A
VAL
76
A
VAL
76
A
THR
58
A
THR
58
A
LEU
62
A
LEU
62
A
ILE
38
A
ILE
38
A
GLY
42
A
GLY
42
A
LEU
94
A
LEU
94
A
GLY
98
A
GLY
98
A
ALA
2
A
ALA
2
A
GLN
7
A
GLN
7
A
THR
112
A
THR
112
A
LEU
118
A
LEU
118
A
HIS
153
A
HIS
153
A
LYS
160
A
LYS
160
A
PHE
136
A
PHE
136
A
VAL
144
A
VAL
144
BINDING SITE FOR RESIDUE NDP A 168
Software
20
BINDING SITE FOR RESIDUE TRR A 170
Software
13
A
TRP
5
A
TRP
5
20
1_555
A
ALA
6
A
ALA
6
20
1_555
A
ILE
13
A
ILE
13
20
1_555
A
GLY
14
A
GLY
14
20
1_555
A
LYS
15
A
LYS
15
20
1_555
A
GLY
17
A
GLY
17
20
1_555
A
GLY
42
A
GLY
42
20
1_555
A
ARG
43
A
ARG
43
20
1_555
A
ARG
44
A
ARG
44
20
1_555
A
THR
45
A
THR
45
20
1_555
A
LEU
62
A
LEU
62
20
1_555
A
THR
63
A
THR
63
20
1_555
A
HIS
64
A
HIS
64
20
1_555
A
GLN
65
A
GLN
65
20
1_555
A
ALA
97
A
ALA
97
20
1_555
A
GLY
99
A
GLY
99
20
1_555
A
ALA
100
A
ALA
100
20
1_555
A
GLN
101
A
GLN
101
20
1_555
A
ILE
102
A
ILE
102
20
1_555
A
TRR
170
C
TRR
20
1_555
A
LEU
4
A
LEU
4
13
1_555
A
TRP
5
A
TRP
5
13
1_555
A
ALA
6
A
ALA
6
13
1_555
A
GLY
17
A
GLY
17
13
1_555
A
LEU
19
A
LEU
19
13
1_555
A
ASP
26
A
ASP
26
13
1_555
A
LEU
27
A
LEU
27
13
1_555
A
PHE
30
A
PHE
30
13
1_555
A
PHE
49
A
PHE
49
13
1_555
A
PRO
50
A
PRO
50
13
1_555
A
ALA
97
A
ALA
97
13
1_555
A
THR
116
A
THR
116
13
1_555
A
NDP
168
B
NDP
13
1_555
1
P 1